Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bolus versus slow Plasma-Lyte 148 infusion after controlled blood loss in healthy volunteers
ACTRN12615000100594Phase 4Completed
- Sponsor
- Austin Hospital
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of plasma-lyte in hemorrhagic shock (2 arms), sponsored by Austin Hospital. Primary endpoint: Oxygen delivery. Started Feb 2015; status: completed.
02
Drugs
plasma-lyte
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on ACTRN12615000100594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000100594.